Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2020-03-24 2020-03-24
Drug Identification Number 02468336 02468336
Brand name PROPOFOL PROPOFOL
Common or Proper name Propofol Injectable Emulsion, BP 1% W/V Propofol Injectable Emulsion, BP 1% W/V
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients PROPOFOL PROPOFOL
Strength(s) 10MG 10MG
Dosage form(s) EMULSION EMULSION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100mL Vials (AIN00003) 100mL Vials (AIN00003)
ATC code N01AX N01AX
ATC description ANESTHETICS, GENERAL ANESTHETICS, GENERAL
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-03-24 2020-03-24
Actual start date 2020-03-24 2020-03-24
Estimated end date 2020-04-15 2020-04-15
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments Customers can choose the alternate format of Propofol 50mL Vials or 100mL Vials if it fits their clinical needs.
Health Canada comments